RLBGX
Price
$36.90
Change
+$0.18 (+0.49%)
Updated
Jul 3 closing price
Net Assets
252.39B
SVBIX
Price
$30.24
Change
+$0.11 (+0.37%)
Updated
Jul 3 closing price
Net Assets
5.92B
Interact to see
Advertisement

RLBGX vs SVBIX

Header iconRLBGX vs SVBIX Comparison
Open Charts RLBGX vs SVBIXBanner chart's image
American Funds American Balanced R6
Price$36.90
Change+$0.18 (+0.49%)
VolumeN/A
Net Assets252.39B
JHancock Balanced I
Price$30.24
Change+$0.11 (+0.37%)
VolumeN/A
Net Assets5.92B
RLBGX vs SVBIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RLBGX vs. SVBIX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBGX is a Buy and SVBIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 252B vs. SVBIX (5.92B). RLBGX pays higher dividends than SVBIX: RLBGX (2.15) vs SVBIX (1.84). RLBGX was incepted earlier than SVBIX: RLBGX (16 years) vs SVBIX (23 years). SVBIX (0.74) is less costly to investors than RLBGX (0.25). SVBIX is a more actively managed with annual turnover of: 67.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than SVBIX: RLBGX (250) vs SVBIX (250000). RLBGX annual gain was more profitable for investors over the last year : 8.24 vs. SVBIX (7.44). SVBIX return over 5 years is better than : 49.21 vs. RLBGX (43.50).
RLBGXSVBIXRLBGX / SVBIX
Total Expense Ratio0.250.7334%
Annual Report Gross Expense Ratio0.250.7434%
Fund Existence16 years23 years-
Gain YTD8.2596.914119%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets252B5.92B4,255%
Annual Yield % from dividends2.151.84116%
Returns for 1 year8.247.44111%
Returns for 3 years36.3140.6989%
Returns for 5 years43.5049.2188%
Returns for 10 years68.5484.8581%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.890.04
+2.16%
Inhibikase Therapeutics
HTLD9.130.06
+0.66%
Heartland Express
BALL58.73-0.01
-0.02%
Ball Corp
CNR72.78-0.47
-0.64%
Core Natural Resources Inc
ADN2.03-0.05
-2.36%
Advent Technologies Holdings Inc.